查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571654

非血管支架市場規模、佔有率和趨勢分析報告：按類型、最終用途、地區、細分市場預測，2024-2030 年

Non-vascular Stents Market Size, Share & Trends Analysis Report By Type (Gastrointestinal Stents, Duodenal, Colonic, Pulmonary (Airway) Stents, Urological Stents), By End Use (Hospitals), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

非血管支架市場成長與趨勢：

根據Grand View Research, Inc.最新報告，預計2030年全球非血管支架市場規模將達22.7億美元，2024年至2030年複合年成長率為4.8%。

由於非血管支架的技術進步和全球微創手術的日益普及，預計市場在預測期內將出現良好的成長。

放射性和生物分解性支架的市場開拓、先進支架設計和材料成分的變化以及超音波超音波引導（EUS）支架置入等新支架留置技術等技術進步預計將有助於支架市場的成長。有多種材料可供選擇，包括由鎳鈦諾、矽膠和鎳鈦諾、不銹鋼和Elgiloy（鈷鉻鎳合金）等合金製成的金屬支架，以及由樹脂、聚氨酯等合成聚合物製成的非金屬支架、和矽膠。

由於醫療保健專業人員對非血管支架置入術等微創技術的高採用率，預計該市場將會成長。這是由於各種好處，例如切口更小、創傷治療更快、疼痛和手術疤痕減少。較小的切口和手術傷口可減少併發症並顯著降低整體手術成本。此外，微創手術可以縮短住院時間，進而降低病患發生院內感染的風險。這可以減少患者的整體醫療保健支出。

非血管支架市場報告亮點

  • 由於膽管癌和膽結石等肝臟和膽管疾病的發生率不斷增加，以及對解決阻塞問題的微創方法的需求不斷成長，2023年市場將由膽管支架主導。
  • 由於食道、胃癌、膽囊、小腸、胰臟、肝癌、腸癌和肛門等胃腸道癌症患者數量迅速增加，預計胃腸道支架細分市場在預測期內將出現最高成長。
  • 由於主要市場參與者在當地的存在、強大的醫療基礎設施以及美國和加拿大胃腸道癌症的高盛行率，預計北美將在預測期內主導市場。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章全球非血管支架市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 全球非血管支架市場分析工具
    • 波特的分析
    • PESTEL分析

第4章 全球非血管支架市場：產品預估及趨勢分析

  • 細分儀表板
  • 非血管支架市場：2023 年和 2030 年產品變化分析
  • 胃腸支架
  • 膽道
  • 十二指腸
  • 冒號
  • 胰臟
  • 食道支架
  • 肺（氣道）支架
  • 矽膠氣道
  • 金屬氣道
  • 泌尿系統支架

第5章全球非血管支架市場：最終用途估算與趨勢分析

  • 細分儀表板
  • 非血管支架市場：2023 年和 2030 年最終用途變化分析
  • 醫院
  • 門診護理中心 (ACS)
  • 專科診所

第6章 全球非血管支架市場：區域估算及趨勢分析

  • 非血管支架市場佔有率（按地區），2023 年和 2030 年，十億美元
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 科威特

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Medtronic
    • BD
    • Boston Scientific Corporation
    • ELLA-CS, sro
    • CONMED Corporation
    • HOBBS MEDICAL, INC
    • Cook
    • TAEWOONG
    • Glaukos Corporation
簡介目錄
Product Code: GVR-1-68038-663-9

Non-vascular Stents Market Growth & Trends:

The global non-vascular stents market size is expected to reach USD 2.27 billion by 2030, registering a CAGR of 4.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness lucrative growth during the forecast period due to technological advancements in the non-vascular stents and rise in the adoption of minimally invasive surgeries across the world.

Technological advancements such as the development of radioactive & biodegradable stents, advanced stent designs & change in material composition, and newer stent placement techniques, such as Endoscopic Ultrasound-guided (EUS) stenting, are expected to help in the growth of the non-vascular stents market over the forecast period. Various materials such as metallic stents, made from alloys include nitinol, silicone & nitinol, stainless steel, and elgiloy (cobalt-chromium-nickel Alloy) and nonmetallic stents, made from synthetic polymers such as resins, polyurethane, and silicone, are used as per the requirement as they offer different features.

Due to the high adoption of minimally invasive techniques, such as nonvascular stenting, by healthcare professionals, the market is expected to grow. This can be attributed to the various advantages such as smaller incisions, rapid wound healing, and reduced pain & surgical scars. Smaller incisions and surgical wounds result in lesser complications, which significantly reduces the overall surgery cost. Moreover, minimally invasive surgeries result in reduced hospital stay, which ultimately lowers the risk of hospital-acquired infections in patients. This helps reduce the overall healthcare expenditure of patients.

Non-vascular Stents Market Report Highlights:

  • Biliary stents dominated the market in 2023 due to increasing occurrence of liver and bile duct diseases such as cholangiocarcinoma and gallstones resulting in a rising need for less invasive methods to deal with blockages.
  • The gastrointestinal stents segment is expected to register the highest growth over the forecast period owing to surge in the number of cases of gastrointestinal cancer, such as cancer of the esophagus, stomach, gallbladder, small intestine, pancreas, liver, bowel, and anus
  • North America is expected to dominate the market during the forecast period owing to the local presence of major market players and robust healthcare infrastructure coupled with a high prevalence of gastrointestinal cancer in the U.S. & Canada.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Non-Vascular Stents Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Billion)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Global Non-Vascular Stents Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Global Non-Vascular Stents Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Non-Vascular Stents Market: Product Movement Analysis, 2023 & 2030 (USD Billion)
  • 4.3. Gastrointestinal Stents
    • 4.3.1. Gastrointestinal Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.4. Biliary
    • 4.4.1. Biliary Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.5. Duodenal
    • 4.5.1. Duodenal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.6. Colonic
    • 4.6.1. Colonic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.7. Pancreatic
    • 4.7.1. Pancreatic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.8. Esophageal Stents
    • 4.8.1. Esophageal Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.9. Pulmonary (Airway) Stents
    • 4.9.1. Pulmonary (Airway) Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.10. Silicone Airway
    • 4.10.1. Silicone Airway Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.11. Metallic Airway
    • 4.11.1. Metallic Airway Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.12. Urological Stents
    • 4.12.1. Urological Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Globe Non-Vascular Stents Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Non-Vascular Stents Market: End Use Movement Analysis, 2023 & 2030 (USD Billion)
  • 5.3. Hospitals
    • 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.4. Ambulatory Care Centers (ACS)
    • 5.4.1. Ambulatory Care Centers (ACS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.5. Specialty Clinics
    • 5.5.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Globe Non-Vascular Stents Market: Regional Estimates & Trend Analysis

  • 6.1. Non-Vascular Stents Market Share, By Region, 2023 & 2030, USD Billion
  • 6.2. North America
    • 6.2.1. North America Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.3. Europe
    • 6.3.1. Europe Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.2. U.K.
      • 6.3.2.1. U.K. Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.4. Italy
      • 6.3.4.1. Italy Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.5. Spain
      • 6.3.5.1. Spain Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.6. Denmark
      • 6.3.6.1. Denmark Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.7. Sweden
      • 6.3.7.1. Sweden Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.8. Norway
      • 6.3.8.1. Norway Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.2. China
      • 6.4.2.1. China Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.4. India
      • 6.4.4.1. India Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Latin America
    • 6.5.1. Latin America Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Saudi Arabia Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.3. UAE
      • 6.6.3.1. UAE Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.4. South Africa
      • 6.6.4.1. South Africa Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Medtronic
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. BD
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Boston Scientific Corporation
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. ELLA - CS, s.r.o.
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. CONMED Corporation
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. HOBBS MEDICAL, INC
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Cook
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. TAEWOONG
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Glaukos Corporation
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives